Encision Inc. (ECIA)
USD 0.35
(0.0%)
USD 0.35
(0.0%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 6.58 Million USD | -10.38% |
| 2023 | 7.34 Million USD | -4.16% |
| 2022 | 7.66 Million USD | 1.72% |
| 2021 | 7.53 Million USD | -1.72% |
| 2020 | 7.67 Million USD | -12.87% |
| 2019 | 8.8 Million USD | 0.55% |
| 2018 | 8.75 Million USD | -1.31% |
| 2017 | 8.87 Million USD | -4.99% |
| 2016 | 9.33 Million USD | -3.46% |
| 2015 | 9.67 Million USD | -8.3% |
| 2014 | 10.54 Million USD | -10.37% |
| 2013 | 11.76 Million USD | -9.41% |
| 2012 | 12.98 Million USD | 11.81% |
| 2011 | 11.61 Million USD | -9.5% |
| 2010 | 12.83 Million USD | 0.37% |
| 2009 | 12.78 Million USD | 6.0% |
| 2008 | 12.06 Million USD | 9.59% |
| 2007 | 11.01 Million USD | 20.63% |
| 2006 | 9.12 Million USD | 13.33% |
| 2005 | 8.05 Million USD | 10.54% |
| 2004 | 7.28 Million USD | 6.95% |
| 2003 | 6.81 Million USD | 40.06% |
| 2002 | 4.86 Million USD | 61.2% |
| 2001 | 3.01 Million USD | 50.71% |
| 2000 | 2 Million USD | 27.65% |
| 1999 | 1.56 Million USD | 19.19% |
| 1998 | 1.31 Million USD | -5.88% |
| 1997 | 1.39 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 1.65 Million USD | -8.47% |
| 2024 Q3 | 1.58 Million USD | -13.39% |
| 2024 FY | 6.58 Million USD | -10.38% |
| 2024 Q4 | 1.52 Million USD | -3.58% |
| 2024 Q2 | 1.82 Million USD | 10.47% |
| 2023 Q3 | 1.68 Million USD | -1.19% |
| 2023 FY | 7.34 Million USD | -4.16% |
| 2023 Q4 | 1.8 Million USD | 7.24% |
| 2023 Q2 | 1.7 Million USD | -20.87% |
| 2023 Q1 | 2.15 Million USD | 34.29% |
| 2022 Q1 | 2 Million USD | -6.56% |
| 2022 FY | 7.66 Million USD | 1.72% |
| 2022 Q4 | 1.6 Million USD | -17.49% |
| 2022 Q3 | 1.94 Million USD | -8.0% |
| 2022 Q2 | 2.11 Million USD | 5.23% |
| 2021 Q1 | 1.34 Million USD | -24.18% |
| 2021 FY | 7.53 Million USD | -1.72% |
| 2021 Q2 | 1.88 Million USD | 39.54% |
| 2021 Q4 | 2.14 Million USD | -0.65% |
| 2021 Q3 | 2.16 Million USD | 14.99% |
| 2020 FY | 7.67 Million USD | -12.87% |
| 2020 Q4 | 1.77 Million USD | -12.8% |
| 2020 Q3 | 2.03 Million USD | 5.98% |
| 2020 Q1 | 1.92 Million USD | -7.45% |
| 2020 Q2 | 1.92 Million USD | -0.26% |
| 2019 Q2 | 2.19 Million USD | -8.61% |
| 2019 FY | 8.8 Million USD | 0.55% |
| 2019 Q4 | 2.08 Million USD | -1.55% |
| 2019 Q3 | 2.11 Million USD | -3.64% |
| 2019 Q1 | 2.4 Million USD | 17.96% |
| 2018 FY | 8.75 Million USD | -1.31% |
| 2018 Q3 | 2.19 Million USD | 1.25% |
| 2018 Q4 | 2.03 Million USD | -6.94% |
| 2018 Q2 | 2.16 Million USD | -8.5% |
| 2018 Q1 | 2.36 Million USD | 6.87% |
| 2017 Q2 | 2.15 Million USD | -5.53% |
| 2017 Q4 | 2.21 Million USD | -0.81% |
| 2017 FY | 8.87 Million USD | -4.99% |
| 2017 Q1 | 2.27 Million USD | -0.52% |
| 2017 Q3 | 2.23 Million USD | 3.67% |
| 2016 Q2 | 2.3 Million USD | -6.28% |
| 2016 FY | 9.33 Million USD | -3.46% |
| 2016 Q4 | 2.28 Million USD | -0.17% |
| 2016 Q3 | 2.29 Million USD | -0.3% |
| 2016 Q1 | 2.45 Million USD | 6.37% |
| 2015 Q4 | 2.3 Million USD | -11.54% |
| 2015 FY | 9.67 Million USD | -8.3% |
| 2015 Q1 | 2.47 Million USD | -1.11% |
| 2015 Q2 | 2.27 Million USD | -7.96% |
| 2015 Q3 | 2.6 Million USD | 14.44% |
| 2014 Q1 | 2.68 Million USD | -2.01% |
| 2014 Q3 | 2.71 Million USD | 2.68% |
| 2014 Q2 | 2.64 Million USD | -1.38% |
| 2014 FY | 10.54 Million USD | -10.37% |
| 2014 Q4 | 2.5 Million USD | -7.81% |
| 2013 Q3 | 3.05 Million USD | 6.3% |
| 2013 Q1 | 3.1 Million USD | -7.99% |
| 2013 Q2 | 2.87 Million USD | -7.32% |
| 2013 FY | 11.76 Million USD | -9.41% |
| 2013 Q4 | 2.73 Million USD | -10.41% |
| 2012 Q1 | 3.18 Million USD | 8.99% |
| 2012 Q4 | 3.37 Million USD | 6.41% |
| 2012 Q2 | 3.26 Million USD | 2.61% |
| 2012 Q3 | 3.16 Million USD | -3.06% |
| 2012 FY | 12.98 Million USD | 11.81% |
| 2011 Q4 | 2.92 Million USD | 0.16% |
| 2011 Q1 | 2.91 Million USD | -8.59% |
| 2011 FY | 11.61 Million USD | -9.5% |
| 2011 Q3 | 2.91 Million USD | 1.78% |
| 2011 Q2 | 2.86 Million USD | -1.61% |
| 2010 FY | 12.83 Million USD | 0.37% |
| 2010 Q1 | 3.17 Million USD | 3.1% |
| 2010 Q2 | 3.21 Million USD | 1.32% |
| 2010 Q3 | 3.26 Million USD | 1.39% |
| 2010 Q4 | 3.18 Million USD | -2.27% |
| 2009 Q2 | 3.34 Million USD | 8.15% |
| 2009 Q4 | 3.07 Million USD | -5.89% |
| 2009 Q1 | 3.09 Million USD | -2.8% |
| 2009 FY | 12.78 Million USD | 6.0% |
| 2009 Q3 | 3.27 Million USD | -2.25% |
| 2008 Q1 | 2.65 Million USD | -5.61% |
| 2008 Q4 | 3.18 Million USD | 1.68% |
| 2008 Q3 | 3.13 Million USD | 1.24% |
| 2008 Q2 | 3.09 Million USD | 16.29% |
| 2008 FY | 12.06 Million USD | 9.59% |
| 2007 Q3 | 2.78 Million USD | 5.12% |
| 2007 Q2 | 2.65 Million USD | -3.73% |
| 2007 FY | 11.01 Million USD | 20.63% |
| 2007 Q4 | 2.81 Million USD | 1.08% |
| 2007 Q1 | 2.75 Million USD | 13.85% |
| 2006 Q1 | 2.28 Million USD | 7.61% |
| 2006 Q4 | 2.41 Million USD | 14.28% |
| 2006 Q3 | 2.11 Million USD | -8.06% |
| 2006 Q2 | 2.3 Million USD | 0.6% |
| 2006 FY | 9.12 Million USD | 13.33% |
| 2005 Q1 | 1.76 Million USD | -7.84% |
| 2005 Q3 | 2.09 Million USD | 1.54% |
| 2005 Q2 | 2.06 Million USD | 17.17% |
| 2005 FY | 8.05 Million USD | 10.54% |
| 2005 Q4 | 2.12 Million USD | 1.38% |
| 2004 Q4 | 1.91 Million USD | 6.83% |
| 2004 FY | 7.28 Million USD | 6.95% |
| 2004 Q3 | 1.79 Million USD | -4.74% |
| 2004 Q2 | 1.88 Million USD | 10.46% |
| 2004 Q1 | 1.7 Million USD | -10.61% |
| 2003 Q3 | 1.81 Million USD | 3.32% |
| 2003 Q2 | 1.75 Million USD | 30.65% |
| 2003 FY | 6.81 Million USD | 40.06% |
| 2003 Q1 | 1.34 Million USD | -10.0% |
| 2003 Q4 | 1.9 Million USD | 5.08% |
| 2002 Q2 | 1.22 Million USD | 19.24% |
| 2002 Q1 | 1.02 Million USD | 2.46% |
| 2002 Q3 | 1.12 Million USD | -8.46% |
| 2002 Q4 | 1.49 Million USD | 33.06% |
| 2002 FY | 4.86 Million USD | 61.2% |
| 2001 FY | 3.01 Million USD | 50.71% |
| 2001 Q4 | 1 Million USD | 18.03% |
| 2001 Q3 | 849.16 Thousand USD | 29.59% |
| 2001 Q2 | 655.24 Thousand USD | 28.3% |
| 2001 Q1 | 510.69 Thousand USD | -0.02% |
| 2000 Q3 | 572.84 Thousand USD | 0.0% |
| 2000 Q4 | 510.82 Thousand USD | -10.83% |
| 2000 FY | 2 Million USD | 27.65% |
| 1999 FY | 1.56 Million USD | 19.19% |
| 1998 FY | 1.31 Million USD | -5.88% |
| 1997 FY | 1.39 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| American Medical Technologies Inc. | 3.19 Million USD | -106.359% |
| Ansell Limited | 1.61 Billion USD | 99.593% |
| Ansell Limited | 1.61 Billion USD | 99.593% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | 184.64 Million USD | 96.433% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | 135.05 Thousand USD | -4776.444% |
| Psykey, Inc. | 419.29 Thousand USD | -1470.689% |
| ConvaTec Group Plc | 2.19 Billion USD | 99.7% |
| ConvaTec Group Plc | 2.14 Billion USD | 99.693% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | - USD | -Infinity% |
| Innovative MedTech Inc. | 1.82 Million USD | -260.885% |
| LifePoint, Inc. | -18.5 Thousand USD | 35699.362% |
| Medite Cancer Diagnostics, Inc. | 6.81 Million USD | 3.334% |
| Paradigm Medical Industries, Inc. | 772 Thousand USD | -753.094% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | 986.22 Thousand USD | -567.79% |
| Reflect Scientific, Inc. | 1.08 Million USD | -509.717% |
| SmileDirectClub, Inc. | 470.74 Million USD | 98.601% |
| Sector 10, Inc. | - USD | -Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 1.87 Billion USD | 99.648% |
| SheerVision, Inc. | 3.49 Million USD | -88.2% |
| United Health Products, Inc. | - USD | -Infinity% |
| Vasamed, Inc. | 1.38 Million USD | -375.071% |
| Wearable Health Solutions, Inc. | 745.09 Thousand USD | -783.901% |
| Yubo International Biotech Limited | 104.28 Thousand USD | -6215.394% |